Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $697,000 - $1.21 Million
-50,000 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$13.89 - $23.16 $347,250 - $579,000
25,000 Added 100.0%
50,000 $758,000
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $732,150 - $922,950
-45,000 Reduced 64.29%
25,000 $485,000
Q1 2019

May 14, 2019

BUY
$12.61 - $22.33 $882,700 - $1.56 Million
70,000 New
70,000 $1.45 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $254M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.